Ryu and DM InvestmentOne other possibility is that as DM is growing significantly on the AI side of its business does management need it to be an intermediary for SCRN in the covid testing business? If by purchasing shares of DM, Andrew Ryu is painting a picture of some very serious near term upside, does the DM connection to SCRN continue to make good business sense. Hand over all the reigns of covid testing to SCRN, including the revenue from devices, and throw all the focus of DM behind AI.
In this case the SCRN bottom line is even better and Andrew Ryu does not really need to devote much energy into SCRN. Lena is beginning to put her stamp on the business as CEO so let her run with it.
Just a thought!